Meeder Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-165
| Closed | -$3.36K | – | 937 |
|
|
2024
Q4 | $3.36K | Buy |
165
+6
| +4% | +$122 | ﹤0.01% | 872 |
|
|
2024
Q3 | $4.63K | Buy |
+159
| New | +$4.63K | ﹤0.01% | 755 |
|
|
2021
Q4 | – | Sell |
-3,669
| Closed | -$186K | – | 1480 |
|
|
2021
Q3 | $186K | Buy |
3,669
+922
| +34% | +$46.7K | 0.01% | 742 |
|
|
2021
Q2 | $215K | Buy |
2,747
+306
| +13% | +$24K | 0.01% | 708 |
|
|
2021
Q1 | $139K | Buy |
+2,441
| New | +$139K | 0.01% | 824 |
|
|
2020
Q4 | – | Sell |
-2,426
| Closed | -$88K | – | 1968 |
|
|
2020
Q3 | $88K | Buy |
2,426
+1,960
| +421% | +$71.1K | 0.01% | 821 |
|
|
2020
Q2 | $13K | Sell |
466
-1,047
| -69% | -$29.2K | ﹤0.01% | 1239 |
|
|
2020
Q1 | $26K | Buy |
+1,513
| New | +$26K | ﹤0.01% | 1135 |
|
|
2019
Q1 | – | Sell |
-318
| Closed | -$7K | – | 1733 |
|
|
2018
Q4 | $7K | Sell |
318
-79
| -20% | -$1.74K | ﹤0.01% | 1329 |
|
|
2018
Q3 | $9K | Buy |
+397
| New | +$9K | ﹤0.01% | 1183 |
|